Table 3.
Feature | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Subtype | ||||
HRpos | Reference | Reference | ||
TNBC | 1.26 (0.72–2.20) | 0.427 | 1.72 (0.88–3.36) | 0.114 |
TMB group | ||||
Low | Reference | Reference | ||
High | 0.52 (0.26–1.03) | 0.061 | 0.45 (0.21–0.94) | 0.033 |
Somatic HRD-related gene status | ||||
Wild type | Reference | Reference | ||
Mutated | 2.52 (1.15–5.53) | 0.022 | 2.62 (1.08–6.40) | 0.034 |
Signature 25 | ||||
Low | Reference | Reference | ||
High | 2.64 (1.13–6.19) | 0.025 | 2.01 (0.83–4.90) | 0.124 |
E2F target enrichment score | ||||
Low | Reference | Reference | ||
High | 1.87 (1.05–3.31) | 0.033 | 1.43 (0.74–2.74) | 0.284 |
AP gene set enrichment score | ||||
Low | Reference | Reference | ||
High | 0.46 (0.26–0.83) | 0.009 | 0.46 (0.23–0.93) | 0.031 |
CI confidence interval, HR hazard ratio